Characterization of aliphatic, cyclic, and aromatic N-terminally “capped” His- d-Phe-Arg-Trp-NH 2 tetrapeptides at the melanocortin receptors

Abstract

The melanocortin system is implicated in multiple physiological pathways including pigmentation, inflammation, erectile function, feeding behavior, energy homeostasis, weight homeostasis, and exocrine gland function, just to list a few. The endogenous agonists for the melanocortin receptors include the gene transcripts derived from the proopiomelanocortin gene and include the core tetrapeptide His-Phe-Arg-Trp sequence postulated to be important for melanocortin receptor selectivity and stimulation. Posttranslational processing of the proopiomelanocortin derived agonists results in the N-terminal acetylation and C-terminal amidation of α-melanocyte stimulation hormone (α-MSH). In this study we generated 25 N-terminally “capped” tetrapeptides containing the core sequence X-His- d-Phe-Arg-Trp-NH 2 and pharmacologically characterized them at the mouse melanocortin MC 1 receptor, melanocortin MC 3 receptor, melanocortin MC 4 receptor, and melanocortin MC 5 receptor. The N-terminal “capping” groups consisted of linear, cyclic, or aromatic moieties and all resulted in full agonist activity at the melanocortin receptors examined in this study. Increasing aliphatic chain length increased potency of the tetrapeptide derivatives, with the addition of octanoyl capping group resulting in 70- to 110-fold increased tetrapeptide potency at the melanocortin MC 1 receptor (EC 50=0.4 nM), melanocortin MC 3 receptor (EC 50=4.0 nM), and melanocortin MC 4 receptor (EC 50=0.4 nM) while only enhancing potency at the melanocortin MC 5 receptor (EC 50=0.8 nM) by 8-fold, compared to the tetrapeptide His- d-Phe-Arg-Trp-NH 2. This octanoyl derivative surprisingly resulted in a 14-fold greater potency than α-MSH (EC 50=5.4 nM) at the mouse melanocortin MC 4 receptor implicated in feeding behavior and obesity. The 3,3,3-triphenylpropionyl derivative resulted in greater than 14 μM agonist potencies at the melanocortin MC 1 receptor, melanocortin MC 3 receptor, and melanocortin MC 4 receptor and possessed a 140 nM agonist EC 50 value at the melanocortin MC 5 receptor. This 3,3,3-triphenylpropionyl-His- d-Phe-Arg-Trp-NH 2 peptide is a 100-fold selective agonist for the melanocortin MC 5 receptor, versus the other melanocortin receptors studied herein, and is the first melanocortin MC 5 receptor selective tetrapeptide derivative reported to date with nanomolar potency.